Cargando…

Anti-inflammatory Effect of Probiotic Limosilactobacillus reuteri KUB-AC5 Against Salmonella Infection in a Mouse Colitis Model

Acute non-typhoidal salmonellosis (NTS) caused by Salmonella enterica Typhimurium (STM) is among the most prevalent of foodborne diseases. A global rising of antibiotic resistance strains of STM raises an urgent need for alternative methods to control this important pathogen. Major human food animal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buddhasiri, Songphon, Sukjoi, Chutikarn, Kaewsakhorn, Thattawan, Nambunmee, Kowit, Nakphaichit, Massalin, Nitisinprasert, Sunee, Thiennimitr, Parameth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419263/ https://www.ncbi.nlm.nih.gov/pubmed/34497597 http://dx.doi.org/10.3389/fmicb.2021.716761

Ejemplares similares

Integrative growth physiology and transcriptome profiling of probiotic Limosilactobacillus reuteri KUB-AC5
por: Jatuponwiphat, Theeraphol, et al.
Publicado: (2021)

Probing Genome-Scale Model Reveals Metabolic Capability and Essential Nutrients for Growth of Probiotic Limosilactobacillus reuteri KUB-AC5
por: Namrak, Thanawat, et al.
Publicado: (2022)

Antimicrobial peptide presenting potential strain-specific real time polymerase chain reaction assay for detecting the probiotic Lactobacillus reuteri KUB-AC5 in chicken intestine
por: Sobanbua, S., et al.
Publicado: (2019)

Therapeutic effects of oral administration of lytic Salmonella phages in a mouse model of non-typhoidal salmonellosis
por: Sukjoi, Chutikarn, et al.
Publicado: (2022)

Clinical Characteristics, Antimicrobial Resistance, Virulence Genes and Multi-Locus Sequence Typing of Non-Typhoidal Salmonella Serovar Typhimurium and Enteritidis Strains Isolated from Patients in Chiang Mai, Thailand
por: Buddhasiri, Songphon, et al.
Publicado: (2023)

Development of high cell density Limosilactobacillus reuteri KUB-AC5 for cell factory using oxidative stress reduction approach
por: Watthanasakphuban, Nisit, et al.
Publicado: (2023)

The Extract of Perilla frutescens Seed Residue Attenuated the Progression of Aberrant Crypt Foci in Rat Colon by Reducing Inflammatory Processes and Altered Gut Microbiota
por: Chantana, Weerachai, et al.
Publicado: (2023)

Microbiota and Probiotics: The Role of Limosilactobacillus Reuteri in Diverticulitis
por: Piccioni, Andrea, et al.
Publicado: (2021)

Probiotic and Functional Properties of Limosilactobacillus reuteri INIA P572
por: Diez-Echave, Patricia, et al.
Publicado: (2021)

Limosilactobacillus reuteri in Health and Disease
por: Abuqwider, Jumana, et al.
Publicado: (2022)

A randomized trial to evaluate the impact of copra meal hydrolysate on gastrointestinal symptoms and gut microbiome
por: Sathitkowitchai, Witida, et al.
Publicado: (2021)

Probiotic Limosilactobacillus Reuteri (Lactobacillus Reuteri) Extends the Lifespan of Drosophila Melanogaster through Insulin/IGF-1 Signaling
por: Lee, Hye-Yeon, et al.
Publicado: (2023)

Development of probiotics beverage using cereal enzymatic hydrolysate fermented with Limosilactobacillus reuteri
por: Yang, Zhoujie, et al.
Publicado: (2022)

Lactobacillus (Limosilactobacillus) reuteri: a probiotic candidate to reduce neonatal diarrhea in calves
por: Schwaiger, Karin, et al.
Publicado: (2023)

Distinct B cell subsets in Peyer’s patches convey probiotic effects by Limosilactobacillus reuteri
por: Liu, Hao-Yu, et al.
Publicado: (2021)

The probiotic and immunomodulation effects of Limosilactobacillus reuteri RGW1 isolated from calf feces
por: Huang, Kailang, et al.
Publicado: (2023)

Pathogen genomics and phage-based solutions for accurately identifying and controlling Salmonella pathogens
por: Lopez-Garcia, Angela V., et al.
Publicado: (2023)

Corrigendum: Pathogen genomics and phage-based solutions for accurately identifying and controlling Salmonella pathogens
por: Lopez-Garcia, Angela V., et al.
Publicado: (2023)

Genome-scale insights into the metabolic versatility of Limosilactobacillus reuteri
por: Luo, Hao, et al.
Publicado: (2021)

Limosilactobacillus reuteri in immunomodulation: molecular mechanisms and potential applications
por: Luo, Zichen, et al.
Publicado: (2023)

Development of Anti-inflammatory Probiotic Limosilactobacillus reuteri EFEL6901 as Kimchi Starter: in vitro and In vivo Evidence
por: Seo, Hee, et al.
Publicado: (2021)

Isolation and Identification of Limosilactobacillus reuteri PSC102 and Evaluation of Its Potential Probiotic, Antioxidant, and Antibacterial Properties
por: Ali, Md. Sekendar, et al.
Publicado: (2023)

Analysis of the infant gut microbiome reveals metabolic functional roles associated with healthy infants and infants with atopic dermatitis using metaproteomics
por: Kingkaw, Amornthep, et al.
Publicado: (2020)

Lactobacillus Reuteri DSM 17938 (Limosilactobacillus reuteri) in Diarrhea and Constipation: Two Sides of the Same Coin?
por: Saviano, Angela, et al.
Publicado: (2021)

Limosilactobacillus reuteri Strains as Adjuvants in the Management of Helicobacter pylori Infection
por: Dargenio, Costantino, et al.
Publicado: (2021)

Effect of Coix Seed Extracts on Growth and Metabolism of Limosilactobacillus reuteri
por: Yang, Zhoujie, et al.
Publicado: (2022)

Spontaneous Riboflavin-Overproducing Limosilactobacillus reuteri for Biofortification of Fermented Foods
por: Spacova, Irina, et al.
Publicado: (2022)

Limosilactobacillus reuteri inhibits the acid tolerance response in oral bacteria
por: Boisen, Gabriella, et al.
Publicado: (2023)

Application of ultrasound and microencapsulation on Limosilactobacillus reuteri DSM 17938 as a metabolic attenuation strategy for tomato juice probiotication
por: Giordano, Irene, et al.
Publicado: (2022)

Oral Vaccination with Engineered Probiotic Limosilactobacillus reuteri Has Protective Effects against Localized and Systemic Staphylococcus aureus Infection
por: Pan, Na, et al.
Publicado: (2023)

The Effect of Limosilactobacillus reuteri on Social Behavior Is Independent of the Adaptive Immune System
por: Dooling, Sean W., et al.
Publicado: (2022)

Genomic, phenotypic, and clinical safety of Limosilactobacillus reuteri ATCC PTA 4659
por: Sendelius, Malin, et al.
Publicado: (2023)

KUB Seminar on Open Access
Publicado: (2007)

Immunomodulatory Effect of Lactobacillus reuteri (Limosilactobacillus reuteri) and Its Exopolysaccharides Investigated on Epithelial Cell Line IPEC-J2 Challenged with Salmonella Typhimurium
por: Kiššová, Zuzana, et al.
Publicado: (2022)

Genome Sequence of the Reuterin-Producing Strain Limosilactobacillus reuteri INIA P572
por: Rodríguez-Mínguez, Eva, et al.
Publicado: (2021)

Draft genome sequence of Limosilactobacillus reuteri, isolated from human breast milk
por: Tyagi, Akanksha, et al.
Publicado: (2023)

In silico, in vitro and in vivo safety evaluation of Limosilactobacillus reuteri strains ATCC PTA-126787 & ATCC PTA-126788 for potential probiotic applications
por: Gangaiah, Dharanesh, et al.
Publicado: (2022)

Assessment of the efficacy of a feed additive consisting of Limosilactobacillus reuteri (formerly Lactobacillus reuteri) DSM 32203 for dogs (NBF LANES)
por: Bampidis, Vasileios, et al.
Publicado: (2022)

Application of Lactobacillus reuteri B1/1 (Limosilactobacillus reuteri) Improves Immunological Profile of the Non-Carcinogenic Porcine-Derived Enterocytes
por: Karaffová, Viera, et al.
Publicado: (2023)

Limosilactobacillus balticus sp. nov., Limosilactobacillus agrestis sp. nov., Limosilactobacillus albertensis sp. nov., Limosilactobacillus rudii sp. nov. and Limosilactobacillus fastidiosus sp. nov., five novel Limosilactobacillus species isolated from the vertebrate gastrointestinal tract, and proposal of six subspecies of Limosilactobacillus reuteri adapted to the gastrointestinal tract of specific vertebrate hosts
por: Li, Fuyong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hnbj83b3rh6ggikk24iv7h33j6